Seven new studies from Mayo Clinic reveal how to identify senescent cells and reduce their inflammatory impact, offering new paths for healthy aging therapies.
A small pilot study from UCSF finds that psilocybin significantly lowers inflammatory markers in Parkinson’s patients, hinting at broader anti-inflammatory benefits.
